The uncertain future of the country’s healthcare system has direct implications for biopharmaceutical and medical device companies, and in turn will affect the way these companies approach medical meetings and healthcare provider education, said Kim Slocum during a keynote address at the Sixth Annual Pharmaceutical Meeting Management Forum. Organized by Medical Meetings and the Center for Business Intelligence, the forum was held March 14–16 in Philadelphia. Speaking about the current ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Healthcare Reform, Public Perception Mean Greater Scrutiny of Pharma Meetings, you'll also gain access to exclusive premium content.

Already registered? here.